China Biologics Market Growth Drivers, Key Developments, and Industry Outlook
The China Biologics Market is being driven by several factors, including rising healthcare requirements, biotechnology innovation, government initiatives, and increasing investment in pharmaceutical research. The market was valued at USD 46.22 billion in 2024 and is forecast to reach USD 278.42 billion by 2035, reflecting a CAGR of 17.73%. One of the primary growth drivers is the...
0 Comments 0 Shares 16 Views 0 Reviews